BofA raised the firm’s price target on PTC Therapeutics (PTCT) to $87 from $76 and keeps a Buy rating on the shares. The firm’s survey of 20 ...

With the battle over extending pandemic-era Affordable Care Act subsidies raging in Congress, organizations across the ...

PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...

This was the stock's second consecutive day of losses.

With 2026 rates already set and consumers starting to learn of premium increases, delays in extending the PTC enhancements ...

Looking back on design software stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Autodesk ...